Arkolith/Insider Trading/GYRE/Form 4

Zhang Ping

DirectorGYRE THERAPEUTICS, INC. (GYRE) · full profile →Form 4 · filed May 28, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
0 non-derivative · 1 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 27, 2025Grant(A)250K—$0250K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001140361-25-020669) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML